Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed May 22, 2026
- Accession no.
- 0001636178-26-000020
- Filed
- May 22, 2026
- Trade date
- May 21, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.64M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $117.76 | +$1,177,600 | 28,876 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −40 | $557.85 | −$22,314 | 28,836 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −320 | $560.03F2 | −$179,209.6 | 28,516 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −920 | $562.01F3 | −$517,049.2 | 27,596 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −2,677 | $563.12F4 | −$1,507,472.24 | 24,919 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −2,081 | $564.10F5 | −$1,173,892.1 | 22,838 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −1,765 | $565.10F6 | −$997,401.5 | 21,073 | Direct | |
| May 21, 2026 | Common Stock | SSaleDisposed | −2,197 | $566.12F7 | −$1,243,765.64 | 18,876 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 70,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $559.99 to $560.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $561.51 to $562.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $562.63 to $563.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $563.63 to $564.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $564.64 to $565.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $565.64 to $566.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.